 |
Previous Article | Next Article 
Volume 17, Number 6,
Issue of March 15, 1997
pp. 1911-1918
Copyright ©1997 Society for Neuroscience
Nedd2 Is Required for Apoptosis after Trophic Factor Withdrawal,
But Not Superoxide Dismutase (SOD1) Downregulation, in Sympathetic
Neurons and PC12 Cells
Carol M. Troy1,
Leonidas Stefanis1, 2,
Lloyd
A. Greene1, and
Michael L. Shelanski1
Departments of 1 Pathology and 2 Neurology,
Taub Center for Alzheimer's Disease Research and Center for
Neurobiology and Behavior, College of Physicians and Surgeons, Columbia
University, New York, New York 10032
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
Activation of cysteine aspartases (caspases) seems to be a required
element of apoptotic death in many paradigms. We have shown previously
that general inhibitors of cysteine aspartases block apoptosis of PC12
cells and sympathetic neurons evoked by either trophic factor (nerve
growth factor and/or serum) deprivation or superoxide dismutase (SOD1)
downregulation. Moreover, activation of a caspase family member similar
or equivalent to the interleukin-1 -converting enzyme (ICE) was
implicated for death caused by SOD1 downregulation, but not withdrawal
of trophic support. The experiments presented here demonstrate that
diminished expression of the cysteine aspartase Nedd2 in PC12 cells and
sympathetic neurons induced by an appropriate vector peptide-linked
antisense oligonucleotide rescues them from death caused by trophic
factor deprivation without inhibiting apoptosis in the same cell types
evoked by SOD1 downregulation. Neither the level (as revealed by
Western immunoblotting) nor the cellular distribution (as revealed
immunohistochemically) of Nedd2 was altered demonstrably by trophic
factor deprivation. However, evidence for proteolytic processing of
Nedd2 (consistent with commencement of activation) was observed in PC12
cells after withdrawal of trophic support. These findings indicate that
neuronal death triggered by different initial causes may be mediated by distinct members of the cysteine aspartase family.
Key words:
Nedd2;
cysteine aspartases;
apoptosis;
neuronal cell
death;
oxidative stress;
trophic factor deprivation
INTRODUCTION
Neuronal death by apoptosis is a normal
feature of development in which it appears that the death program is
triggered by the failure of a given neuron to compete for limiting
supplies of target-derived neurotrophic factors. Neurons also undergo
apoptotic death in the postdevelopmental period when deprived of
appropriate trophic factors or when subjected to any of a variety of
stresses and injuries. Apoptosis also accounts for at least a portion
of cellular loss in degenerative neurological diseases, including Alzheimer's and amyotrophic lateral sclerosis (Coyle and Puttfarcken, 1993 ; Brown, 1995 ; Schapira, 1995 ; Williams, 1995 ).
Neuronal apoptotic death may be precipitated by widely different
initiating causes. In the rat pheochromocytoma PC12 line, a commonly
used model for neuronal differentiation and cell death, apoptosis may
be triggered by either trophic factor/nerve growth factor (NGF)
withdrawal (Greene, 1978 ; Batistatou and Greene, 1991 ; Rukenstein et
al., 1991 ; Mesner et al., 1992 ; Pittman et al., 1993 ; Lindenboim et
al., 1995 ) or oxidative stress induced by downregulation of
Cu2+/Zn2+ superoxide dismutase (SOD1) (Troy and
Shelanski, 1994 ; Troy et al., 1996a -c). The initiating mechanisms of
death seem to be distinct in each instance. Apoptosis triggered by NGF
deprivation is blocked by cAMP analogs (Rydel and Greene, 1988 ;
Rukenstein et al., 1991 ) and high concentrations of
N-acetylcysteine (Ferrari et al., 1995 ), whereas these
agents do not inhibit death induced by downregulation of SOD1 (Troy et
al., 1996a ,c). In contrast, the latter is blocked by vitamin E (Troy
and Shelanski, 1994 ) and inhibitors of nitric oxide (NO) synthase (Troy
et al., 1996a ), which have no effect on apoptosis evoked by NGF
withdrawal (Ferrari et al., 1995 ; Farinelli et al., 1996 ). Despite
these initial mechanistic differences, there is evidence for common or
similar downstream elements in the pathways that lead to death in both
paradigms. In particular, inhibition studies implicate cysteine
aspartases as obligate elements of the cell death mechanism in both
initiating
causes
of death (Troy et al., 1996b ). However, even at the level of cysteine
aspartases, our findings have suggested the presence of parallel
pathways. Apoptosis after SOD1 downregulation is suppressed by the
peptide YVAD, a potent inhibitor of the interleukin-1-converting enzyme (ICE), by blocking antibodies to IL-1 , and by the IL-1 receptor antagonist IL-1Ra, although such agents have little or no effect on
death caused by trophic factor/NGF withdrawal. These findings suggest
that ICE itself, or another enzyme with pro-IL-1 cleaving activity,
is required for death in the SOD1 downregulation paradigm, whereas a
different cysteine aspartase is required for death in the case of
trophic factor deprivation (Troy et al., 1996b ).
Fig. 1.
Downregulation of Nedd2 in PC12 cells by
Penetratin 1-linked antisense oligonucleotide to Nedd2 (V-ANedd). Naive
and neuronally differentiated PC12 cells (pretreated for at least
7 d with NGF) were plated on Matrigel-coated multichamber slides.
V-ANedd (400 nM) was added to the indicated cultures after
plating. Naive cultures were grown in RPMI 1640 medium with 5%
FCS/10% horse serum; neuronal cultures were grown in RPMI 1640 medium
with 1% horse serum and NGF (100 ng/ml). After overnight maintenance,
cells were fixed in ice-cold methanol and then immunostained with
anti-N-Nedd (see Materials and Methods). Cells were observed with a
Nikon fluorescence microscope, 120× magnification.
[View Larger Version of this Image (71K GIF file)]
Fig. 2.
Cellular localization of Nedd2 before and after
trophic factor deprivation. Naive and neuronally differentiated cells
were grown with serum and serum and NGF, respectively. Then the cells were plated (as described in Materials and Methods) in serum-free RPMI
1640 medium for 20 hr with (+NGF) or without
( NGF) NGF, as indicated. Cultures were stained
with anti-N-Nedd and were observed with a Bio-Rad MRC600 confocal
microscope, 1600× magnification.
[View Larger Version of this Image (82K GIF file)]
Fig. 3.
Regulation of Nedd2 by V-ANedd. Naive PC12 cells
were grown for 24 hr in serum-free RPMI 1640 medium in the presence or
absence of NGF (100 ng/ml) and with or without
V-ANedd (400 nM) or V-SNedd (400 nM), as indicated. The cells were extracted in sample
buffer, the extracts were boiled, and equal amounts of protein were
resolved by 10% SDS-PAGE and transferred to nitrocellulose. Blots were probed with (A) anti-N-Nedd at 1:500 or
(B) anti-C-Nedd at 1:330, and staining was visualized
with ECL. Bands were quantified with Scion Image software and
normalized against peripherin levels. The level of downregulation is
representative of that obtained in five independent experiments.
[View Larger Version of this Image (37K GIF file)]
Fig. 4.
V-ANedd rescues PC12 cells from serum
deprivation, but not from SOD1 downregulation. A,
V-ANedd differentially protects PC12 cells from serum deprivation. For
serum deprivation (4 left-hand bars) cells were washed
extensively, as described in Materials and Methods, and the indicated
additives (100 ng/ml NGF, 400 nM V-ANedd, or 200 nM
V-ICEinh) were added at the time
of plating in serum-free RPMI 1640 medium. For SOD1 downregulation (4 right-hand bars), PC12 cells were replated on fresh
collagen-coated 24-well dishes in complete medium (RPMI 1640 medium
with 10% horse serum/5% fetal bovine serum) with 50 nM
V-ASOD1 (vector-linked antisense oligonucleotide to
SOD1). Additives (800 nM V-ANedd and 25 nM V-ICEinh) were
included as indicated. Control cells were in complete medium. Cultures
were incubated for 24 hr and lysed, and the number of intact nuclei was
counted. The numbers of surviving cells are expressed relative to the
number in the control cultures (designated as 100). Here, as in past studies (Greene and Tischler, 1976 ; Rukenstein et al., 1991 ; Troy et
al., 1996a ,b), NGF or complete medium promotes survival of all cells
initially plated. Experiments were performed in triplicate wells, and
data are expressed as mean ± SEM. B,
Dose-response curve for protection from serum deprivation by V-ANedd.
PC12 cells were washed for trophic factor deprivation and plated in
serum-free medium with the indicated concentrations of V-ANedd. Cell
survival relative to the number present with the addition of NGF was
measured at 1 d. C, V-ANedd does not block the
V-ASOD1-induced increase of IL-1 production. PC12 cells were plated
with the indicated additives (50 nM V-ASOD1,
25 nM V-ICEinh, and
800 nM V-ANedd). Controls contained
complete medium. After 20 hr, media were removed, and IL-1 was
measured by ELISA with the Intertest-1 X kit. Data are expressed as
mean ± SEM (n = 3).
[View Larger Version of this Image (30K GIF file)]
Fig. 5.
Neuronally differentiated PC12 cells are rescued
from NGF deprivation, but not from SOD1 downregulation, by V-ANedd.
A, V-ANedd differentially protects neuronally
differentiated PC12 cells from apoptosis caused by NGF withdrawal. PC12
cells were neuronally differentiated by exposure to NGF (100 ng/ml) for
at least 7 d in RPMI 1640 medium plus 1% horse serum. Cells were
deprived of serum and NGF and replated as described in Figure 4.
Additives present at the time of plating included 400 nM
V-ANedd, 400 nM V-ICEinh, or 100 ng/ml
NGF (4 left-hand bars). For SOD1 downregulation (4 right-hand bars) neuronally
differentiated PC12 cells were plated in RPMI 1640 medium plus 1%
horse serum, with 100 ng/ml NGF. At the time of plating, cultures were
incubated, as indicated, with 50 nM V-ASOD1
and with the indicated additives (800 nM
V-ANedd and 50 nM
V-ICEinh). Cell survival was determined after 1 d and expressed as in Figure 4.
B, Dose-response curve for protection from NGF
deprivation by V-ANedd. Neuronally differentiated PC12 cells were
washed as above for NGF deprivation and plated in serum-free medium
with the indicated concentrations of V-ANedd. Cell survival relative to
the number present with the addition of NGF was quantified at 1 d.
C, V-ANedd provides long-term protection against NGF
deprivation. Neuronally differentiated PC12 cells were deprived of NGF
and serum and plated as described in A. V-ANedd (400 nM) was included at the time of NGF deprivation and
replenished 1 d later. Cell survival was determined at the indicated times as in Figure 4.
[View Larger Version of this Image (27K GIF file)]
Fig. 6.
V-ANedd protects sympathetic neurons from NGF
withdrawal, but not from oxidative stress. A, V-ANedd
protects sympathetic neurons from NGF withdrawal. At the time of NGF
deprivation, V-ANedd (400 nM) was added to the cultures, as
indicated. Numbers of surviving neurons were determined at the
indicated times, as described in Materials and Methods, and are
reported as relative to the number present in each culture at the time
of NGF withdrawal. B, V-ANedd does not protect
sympathetic neurons from death induced by SOD1 downregulation and
nitric oxide generation. Sympathetic neurons, after 6 d in
culture, were maintained with NGF (100 ng/ml) and mixtures of the
following additives as indicated: V-ASOD1 (50 nM), SNAP (100 µM), and
V-ANedd (400 nM). Numbers of surviving neurons were determined at the indicated times, as above.
[View Larger Version of this Image (17K GIF file)]
Fig. 7.
Morphology of cells rescued by V-ANedd.
Photomicrographs of cells treated as described in the preceding
figures. Top row, Naive PC12 cells:
left, in serum-free RPMI 1640 medium with 100 ng/ml NGF
(24 hr); middle, in RPMI 1640 medium alone (24 hr); right, in serum-free RPMI 1640 medium with 400 nM V-ANedd (24 hr). Middle row,
Neuronal PC12 cells: left, replated in
serum-free RPMI 1640 medium with 100 ng/ml NGF (24 hr);
middle, replated in serum-free RPMI 1640 medium without
NGF (24 hr); right, replated in serum-free RPMI 1640 medium with 400 nM V-ANedd (24 hr). Bottom row, SCG (sympathetic) neurons:
left, cultured with 100 ng/ml NGF (3 d);
middle, cultured in NGF-free medium with anti-NGF (3 d);
right, cultured in NGF-free medium with anti-NGF plus
400 nM V-ANedd (3 d). Phase contrast optics, 80×
magnification.
[View Larger Version of this Image (131K GIF file)]
In light of the above, the objective of the present study was to
identify a specific cysteine aspartase that is required for neuronal
apoptosis triggered by trophic factor deprivation. The cysteine
aspartase Nedd2 is the rodent homolog of the human Ich-1/NEDD2 ICE
family member and is highly expressed in neurons and PC12 cells (Kumar
et al., 1994 ; Wang et al., 1994 ). Overexpression of Nedd2/Ich-1 causes
apoptosis in fibroblasts and neuroblastoma cells (Kumar et al., 1994 ),
and expression of a NEDD2 antisense construct protects a
hematopoietic-derived cell line from death evoked by cytokine
deprivation (Kumar, 1995 ). In the experiments reported here, we used a
novel vector-linked antisense oligonucleotide to suppress Nedd2
expression in cultured PC12 cells and sympathetic neurons. Our findings
indicate that Nedd2 plays a required role in neuronal apoptosis caused
by loss of trophic support. In contrast, it does not seem to be
required for death caused by SOD1 downregulation; thus, distinct
cysteine aspartases mediate neuronal apoptosis triggered by different
causes in the same cell.
MATERIALS AND METHODS
Cell culture
PC12 cells. PC12 cells were grown as previously
described (Greene and Tischler, 1976 ) on rat-tail collagen-coated
dishes in RPMI 1640 medium containing 5% fetal calf serum and 10%
heat-inactivated horse serum (complete medium). NGF-primed (neuronally
differentiated) PC12 cells were grown for at least 7 d in RPMI
1640 medium plus 1% horse serum and NGF (100 ng/ml). For cell survival
assays involving trophic factor deprivation, cells (either naive or
NGF-pretreated) were washed extensively in serum-free RPMI 1640 medium
and replated on fresh collagen-coated 24-well dishes, as previously
described (Rukenstein et al., 1991 ), in RPMI 1640 medium lacking serum
or NGF. For SOD1 downregulation survival assays, cells were replated in
complete medium with V-ASOD1 (vector-linked antisense oligonucleotide to SOD1, 50 nM), as previously described (Troy et al.,
1996a ). Various concentrations of V-ANedd (vector-linked antisense
oligonucleotide to Nedd2) were included in the medium as indicated.
Numbers of viable cells per culture were determined by quantifying
intact nuclei, as previously described (Rukenstein et al., 1991 ).
Counts were performed in triplicate and reported as mean ± SEM.
Sympathetic neurons. Sympathetic neuron cultures were
prepared from 2-d-old rat pups, as previously described (Ferrari et al., 1995 ). Cultures were grown in 24-well collagen-coated dishes in
RPMI 1640 medium plus 10% horse serum with mouse NGF (100 ng/ml). One
day after plating, uridine and 5-fluorodeoxyuridine (10 µM each) were added to the cultures and left for 3 d
to eliminate non-neuronal cells. On the sixth day after plating, NGF
was removed by washing the cultures three times with RPMI 1640 medium
plus 10% horse serum, followed by the addition of medium containing anti-mouse NGF (1:200, Sigma, St. Louis, MO) with or without V-ANedd. Each culture was scored, as previously described (Rydel and Greene, 1988 ), as numbers of living, phase-bright neurons at various times. Three replicate cultures were assessed for each condition, and data
were normalized to numbers of neurons present in each culture at the
time of NGF withdrawal and reported as mean ± SEM.
Synthesis of V-ANedd
Oligonucleotides bearing an SH group at their 5 end and an NH
group at their 3 end were purchased from Operon (Alameda, CA). As
previously described (Troy et al., 1996a ), oligonucleotides were
resuspended in deionized water, an equimolar ratio of Penetratin 1 (Oncor, Gaithersburg, MD) was added, and the mixture was incubated at
37°C for 1 hr. The yield of the reaction, estimated by SDS-PAGE followed by Coomassie blue staining, was routinely above 50%. A
scrambled sequence of the antisense oligonucleotide (same base composition, different order), defined as V-SNedd, was synthesized for
use as a control.
Antibody preparation
Anti-N-Nedd2, a polyclonal rabbit antiserum, was produced for us
by Multiple Peptide Systems (San Diego, CA) using a 16-amino-acid synthetic peptide homologous to the N terminus (amino acids 1-16) as
the antigen. The antiserum was affinity-purified with peptide bound to
Sulfo-Link gel. Antiserum against a C-terminal peptide of Nedd2 (Nedd2
p12 C20) was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA).
Immunofluorescence
PC12 cells were plated on coverslips or on eight-well
multichamber slides (LabTek, VWR Scientific Products) coated with
Matrigel. After growth overnight, cells were fixed in ice-cold methanol and then immunostained as described (Troy et al., 1990 ). The primary antibody was either affinity-purified antibody Anti-N-Nedd2 or Nedd2
p12 C20 (Santa Cruz Biotechnology) at a dilution of 1:200. The
secondary antibody was fluorescein isothiocyanate-conjugated goat
anti-rabbit (Cappel, Durham, NC) at 1:100. For visualization with a
Nikon fluorescence microscope, slides were coverslipped with
Aqua-mount. Confocal microscopy was done on a Bio-Rad (Richmond, CA)
600 confocal microscope.
Western blotting
PC12 cells grown with or without V-ANedd or V-SNedd were
harvested in SDS containing sample buffer and immediately boiled. Equal
amounts of protein were separated by 10% PAGE, transferred to
nitrocellulose, and immunostained as described (Troy et al., 1992 ). The
affinity-purified anti-N-Nedd2 was used at a dilution of 1:500. The
commercial antiserum Nedd2 p12 C20 (Santa Cruz Biotechnology) was used
at a dilution of 1:350. Visualization was with ECL, using goat
anti-rabbit peroxidase at 1:1000. The relative intensity of the protein
bands was quantified with Scion Image 1.55 software, and samples were
normalized by stripping and reprobing the blots with anti-peripherin
antibody.
Assay of IL-1
IL-1 was quantified by ELISA with the Intertest-1 X kit
(Genzyme, Cambridge, MA), as previously described (Troy et al., 1996b ). PC12 cells were grown as described above, on 24-well plates, in 500 µl of medium. After 1 d of incubation, medium was removed and
IL-1 was measured following the manufacturer's instructions; the
number of viable cells in each well was quantified.
RESULTS
A vector-linked Nedd2 antisense oligonucleotide
(V-ANedd) downregulates Nedd2 protein
To suppress expression of Nedd2 in neuronal cells, we
designed an antisense oligonucleotide corresponding to the last 12 bases in the 5 UTR and the first 9 bases in the coding region of the Nedd2 transcript (Kumar et al., 1994 ). The antisense oligonucleotide (ANedd; GCTCGGCGCCGCCATTTCCAG) is not homologous to any other reported
mRNA sequence, including those of the other known cysteine aspartases.
The oligonucleotide was linked to the vector peptide Penetratin 1 (V-)
(Theodore et al., 1995 ; Troy et al., 1996a ) to enhance its uptake by
cells. The control-scrambled oligonucleotide (SNedd;
CCGTAGCGTAGCTCCGCCTGC) also was linked to vector peptide. This
vector-linked strategy significantly enhances the potency of antisense
oligonucleotides and permits their use in the presence of serum (Troy
et al., 1996a ).
Using an affinity-purified anti-peptide antiserum (anti-N-Nedd2)
generated against a synthetic N-terminal Nedd2 peptide, we examined the
expression of Nedd2 in naive and neuronal PC12 cells before and after
exposure to V-ANedd. As revealed by immunohistochemistry, in control
cells the anti-N-Nedd2 staining was primarily cytoplasmic. This
decreased to almost undetectable levels when the cells were pretreated
for 24 hr with 400 nM V-ANedd (Fig. 1). In contrast, no
change in staining was observed after exposure to 400 nM
V-SNedd. Comparable results were found with a commercial antibody
generated to a C-terminal peptide of Nedd2 (anti-C-Nedd2; data not
shown). Confocal microscopy with either the N-terminal (Fig. 2) or the C-terminal (data not shown) antiserum demonstrated that the Nedd2 staining pattern does not change substantially after 20 hr of trophic
factor deprivation (Fig. 2) in either naive or neuronal PC12 cells or
after SOD1 downregulation (data not shown). In all cases staining was
mainly cytoplasmic with one to two foci of staining seen in many
nuclei. In the case of anti-N-Nedd2, all staining was abolished by
preincubation with the immunizing peptide.
By Western blot analysis anti-N-Nedd2 recognizes a major band at 53 kDa
in whole PC12 cell lysates (Fig. 3A). The same major band
was identified with the commercial C-Nedd antibody (Fig. 3B). This apparent molecular weight is in agreement with
that calculated from the predicted sequence of the Nedd2 protein (51 kDa). There are also three bands of lesser intensity seen with both
antibodies at 70, 60, and 45 kDa. An identical pattern was seen with
neuronally differentiated PC12 cells and a similar pattern with
cultured sympathetic neurons. Specificity was assessed by absorption of
the antiserum with the peptide to which it was generated and showed
loss of signal by each of the above species (data not shown). A minor
band at 19 kDa was seen on occasion at varying intensity when the
N-terminal antibody was used. The major band and the additional
molecular weight minor bands were downregulated by 60-70%
(n = 4) after 18-22 hr treatment with V-ANedd (Fig. 3). In contrast, there was no downregulation of CPP32 on blots of the
same samples probed with anti-CPP32 (data not shown), indicating specificity of V-ANedd treatment for Nedd2. V-SNedd, the control oligonucleotide, did not downregulate any of the bands. None of the
bands detected by Western blot appeared to be up- or downregulated to a
substantial degree in response to either trophic factor withdrawal or
short (2-24 hr) or long-term (10-14 d) NGF treatment. However, after
withdrawal of trophic support from naive or primed PC12 cells, a
cleavage product of ~36 kDa was detectable by immunoblotting with the
N-terminal antiserum before onset of cell death (data not shown).
Differential effects of V-ANedd on PC12 cell death
To evoke apoptotic neuronal death by trophic factor deprivation,
we withdrew NGF and/or serum from cultures of PC12 cells (either naive
or neuronally differentiated by NGF pretreatment; Greene and Tischler,
1976 ) and neonatal rat sympathetic neurons, as previously described
(Rydel and Greene, 1988 ; Ferrari et al., 1995 ; Troy et al., 1996a ).
Oxidative stress was induced by exposing cultures to the V-linked
copper/zinc SOD1 antisense construct V-ASOD1, which downregulates SOD1
and induces apoptosis in PC12 cells (Troy and Shelanski, 1994 ; Troy et
al., 1996a -c). In each of these paradigms, ~40-60% of the cells
underwent apoptosis within 24 hr.
V-ANedd protected naive PC12 cells from death caused by serum
deprivation, with maximal protection at 400 nM when added
at the same time as serum withdrawal (Figs. 4, 7). In this and all subsequent experiments, the scrambled V-SNedd construct had no effect
on survival or death. Pretreatment of cultures for 4 hr with 50 nM V-ANedd shifted the dose-response curve to the left so
that maximal survival was obtained with 100 nM V-ANedd. In contrast, there was no protection from SOD1 downregulation, even at 800 nM (Fig. 4), and pretreatment with V-ANedd was without effect. However, V-ANedd did downregulate Nedd2 in the presence of
V-ASOD1, precluding competition by the two vector-linked constructs for
cell entry (data not shown). The same concentrations of V-ANedd also
protected neuronally differentiated PC12 cells from apoptosis caused by
NGF withdrawal (Fig. 5A), but, again, not from
downregulation of SOD1 (Fig. 5B). Two successive additions
of V-ANedd, at the time of NGF deprivation and 1 d later,
maintained survival of >75% of the cells through 4 d (Fig.
5C). Although V-ANedd maintained survival, it did not mimic
the actions of NGF in promoting either rapid flattening of naive PC12
cells or neurite outgrowth from neuronally differentiated cells (Fig.
7).
Death of PC12 cells evoked by SOD1 downregulation, but not by
withdrawal of trophic support, is associated with enhanced release of
IL-1 , and this is blocked by the general inhibitor of cysteine aspartase activity V-IQACRG (V-ICEinh) (Troy et al.,
1996b ). As illustrated in Figure 4C, V-ANedd did not affect
IL-1 release after exposure to ASOD1. This indicates that V-ANedd
does not affect processing of pro-IL-1 and that this is not the
mechanism by which it blocks death caused by trophic factor
deprivation. The data in Figures 4 and 5 also show that, as expected,
V-ICEinh protects cells from both trophic factor
deprivation and SOD1 downregulation.
V-ANedd protects sympathetic neurons from NGF deprivation, but not
from oxidative stress
Parallel results were obtained with sympathetic neurons subjected
to NGF deprivation. A single addition of V-ANedd at the time of NGF
withdrawal resulted in >60% survival after 4 d and 25% survival
at 8 d; at these times all neurons in control cultures were dead
(Fig. 6). Although V-ANedd promoted survival, it did not maintain the
neurites of NGF-deprived neurons (Fig. 7). Readdition of NGF to such
cultures resulted in the reappearance of healthy neurites and
maintenance of cell number (data not shown), thereby confirming
neuronal survival and function in the presence of V-ANedd.
Exposure of cultured sympathetic neurons to antisense SOD1 alone
has proved insufficient to produce death although, as for PC12 cells,
this treatment reduces SOD1 levels by 50%. In PC12 cell cultures,
death caused by SOD1 downregulation requires endogenous NO synthase
activity and appears because of generation of peroxynitrite (Troy et
al., 1996a ). Consistent with this, when V-ASOD1 and the NO generator
SNAP (S-nitrosopenicillamine) were added simultaneously to
cultured sympathetic neurons, even in the presence of NGF, ~50% of
the cells underwent apoptotic death within 24 hr. Treatment with the NO
generator in the absence of SOD1 downregulation did not produce death
of either sympathetic neurons or PC12 cells (Farinelli et al., 1996 ).
As in our previous study with PC12 cells (Troy et al., 1996b ), the
general inhibitor of cysteine aspartase activity, V-IQACRG
(V-ICEinh), prevented sympathetic neuron death evoked by
V-ASOD1+SNAP (Fig. 6). In contrast, V-ANedd was without effect in this
paradigm (Fig. 6B).
DISCUSSION
In the present studies, we used an antisense construct to
downregulate the cysteine aspartase Nedd2 in neuronal cells and found
that this inhibited death caused by withdrawal of trophic support, but
not by oxidative stress. Multiple aspects of our studies support the
specificity and utility of our reagents. The major species recognized
by both our N-terminal Nedd2 antiserum and a commercial Nedd2
C-terminal antiserum on Western blots migrated at an apparent
Mr of 53 kDa. This corresponds closely to the
predicted Mr of the Nedd2 protein, based on the
sequence of the nedd2 transcript from mouse (Kumar, 1995 ) as
well as rat (H. Qi and L. Stefanis, unpublished data). Recognition of
this species by anti-N-Nedd2 was abolished in the presence of excess
immunizing peptide. Both antisera also provided similar patterns of
cellular staining, which, in the case of anti-N-Nedd2, was eliminated
by preincubation with the immunizing peptide. Exposure to theV-ANedd
antisense construct yielded significant downregulation of Nedd2 protein as assessed by Western blotting and immunostaining with the two different antisera. To assess the specificity of the antisense construct, we also tested V-SNedd, a scrambled version of V-ANedd, and
observed that it did not affect Nedd2 protein levels, staining of cells
with anti-Nedd2, or cell death. Moreover, the observation that V-ANedd
does not promote survival of neuronal cells after SOD1 downregulation
seems to rule out nonspecific antiapoptotic actions of this construct.
Finally, V-ANedd effectively suppressed death of serum-deprived naive
PC12 cells. In such cultures, apoptosis does not require de
novo protein translation (Rukenstein et al., 1991 ), and thus this
finding seems to exclude potential nonspecific effects of the antisense
construct on synthesis of proteins required for death.
The results of these experiments argue for the existence of at least
two distinct parallel pathways to apoptotic cell death in the same
neuron. The choice of one or the other pathway is a function of the
initial insult to the cell. When SOD1 in PC12 cells is downregulated to
~40% of its control levels, apoptosis occurs (Troy and Shelanski,
1994 ). This process seems to be mediated by peroxynitrite (Troy et al.,
1996a ), although the critical target of peroxynitrite in this model has
not been identified. Cultured rat sympathetic neurons survive the
downregulation of SOD1 itself but die rapidly when this treatment is
coupled with the generation of nitric oxide. Downregulation of SOD1 in
PC12 cells is accompanied by an increase in the release of IL-1 ,
suggesting the activation of an ICE-like enzyme (Troy et al., 1996b ).
In this case, death can be blocked by addition of anti-IL-1 or the
IL-l receptor antagonist (IL-1R ) to the medium. Death of both PC12
and sympathetic neurons caused by SOD1 downregulation also can be
blocked with a variety of inhibitors of the ICE family of proteases
(Troy et al., 1996b ), but interestingly not by the downregulation of
Nedd2. V-ANedd does not alter the release of IL-1 from
V-ASOD1-treated cells. These data point strongly to the involvement of
ICE itself or an ICE-like activity in this model of
free-radical-induced cell death and seem to exclude an obligatory role
of Nedd2.
In contrast to the SOD1 downregulation paradigm, antibodies to IL-1
do not rescue PC12 cells and sympathetic neurons from serum and/or
trophic factor withdrawal. Moreover, the ICE antagonist peptide
ZYVAD-CMK, which effectively rescues the cells from downregulation of
SOD1, has negligible effects on death provoked by loss of trophic support (Troy et al., 1996b ). However, downregulation of Nedd2 in
serum-deprived naive PC12 cells and in NGF-deprived primed PC12 cells
and sympathetic neurons rescues them from apoptotic death, pointing to
a requisite role of Nedd2 in this process.
Our extracts show a major band at 53 kDa, agreeing with the predicted
molecular weight of Nedd2 (Kumar et al., 1994 ). There are also three
minor bands that are detected by both antibodies, two of which are
higher than the calculated molecular weight for Nedd2. Although the
original report on Nedd2 reported that translation of the construct
resulted in a major band of 53 kDa and several minor bands of 45 and 19 kDa (Kumar et al., 1994 ), the detection of higher molecular weight
bands by antibodies against both the C and N termini of Nedd2 and their
specific downregulation by V-ANedd strongly suggests that they are
Nedd2 products. These bands also are seen after in vitro
transcription translation of rat Nedd2 (Qi and Stefanis, unpublished
data).
Previous studies have shown that overexpression of Nedd2 can induce
apoptotic death and that an antisense construct can rescue cells from
apoptosis (Kumar et al., 1994 ; Kumar, 1995 ). The observations presented
here extend these findings by demonstrating directly that Nedd2 protein
levels are downregulated in neuronal cells by antisense treatment and,
more significantly, that Nedd2 is required for neuronal cell death
resulting from trophic factor withdrawal and not required when neuronal
death is induced by SOD1 downregulation. In addition, we observed that
Nedd2 is processed to a 36 kDa cleavage product on withdrawal of
trophic support. Cleavage of Nedd2 also has been reported in another
death paradigm (Srinivasan et al., 1996 ). ICE is processed
proteolytically to an intermediate 35 kDa peptide that is cleaved
further to generate the active form, p20 (Thornberry et al., 1992 ;
Yamin et al., 1996 ). The 36 kDa Nedd2 cleavage product most likely
represents such an intermediate form.
Our results argue against the existence of a single "final common
pathway" leading to apoptotic cell death. In the two paradigms presented here, trophic factor deprivation and SOD1 downregulation, the
general scheme is similar in that each pathway requires a cysteine
aspartase but shows marked selectivity in the specific enzyme required.
The differential association of specific cysteine aspartases with
apoptosis evoked by different means may account for the proliferation
of this family in vertebrates. The use of distinct cysteine aspartases
by the same cells to promote death from different initiating stimuli
raises the possibility that this selectivity can be exploited for the
treatment of specific neurodegenerative disorders.
FOOTNOTES
Received Oct. 30, 1996; revised Dec. 19, 1996; accepted Dec. 30, 1996.
This work was supported by Javits Neuroscience Investigator Awards from
the National Institute of Neurological Disorders and Stroke (NINDS)
(M.L.S. and L.A.G.); the Muscular Dystrophy Association of America
(C.M.T.); NINDS, National Institute on Aging, the Blanchette Rockefeller Foundation, the Amyotrophic Lateral Sclerosis Association, and the March of Dimes (L.A.G.); and by the Lucille P. Markey Trust
(L.S.). We thank Dr. Adriana Rukenstein for excellent assistance with
cell culture, Dr. Richik Ghosh for confocal microscopy, and Dan Clayton
for technical assistance.
Correspondence should be addressed to Dr. Carol M. Troy, Department of
Pathology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032.
REFERENCES
-
Batistatou A,
Greene LA
(1991)
Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity.
J Cell Biol
115:461-471 .
[Abstract/Free Full Text]
-
Brown Jr RH
(1995)
Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice.
Cell
80:687-692 .
[Web of Science][Medline]
-
Coyle JT,
Puttfarcken P
(1993)
Oxidative stress, glutamate, and neurodegenerative disorders.
Science
262:689-695 .
[Abstract/Free Full Text]
-
Farinelli SE,
Park DS,
Greene LA
(1996)
Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism.
J Neurosci
16:2325-2334 .
[Abstract/Free Full Text]
-
Ferrari G,
Yan CYI,
Greene LA
(1995)
N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells.
J Neurosci
15:2857-2866 .
[Abstract]
-
Greene LA
(1978)
Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium.
J Cell Biol
78:747-755 .
[Abstract/Free Full Text]
-
Greene LA,
Tischler AS
(1976)
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.
Proc Natl Acad Sci USA
73:2424-2428 .
[Abstract/Free Full Text]
-
Kumar S
(1995)
Inhibition of apoptosis by the expression of antisense Nedd2.
FEBS Lett
368:69-72 .
[Web of Science][Medline]
-
Kumar S,
Knioshita M,
Noda M,
Copeland NG,
Jenkins NA
(1994)
Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1
-converting enzyme.
Genes Dev
8:1613-1626 .
[Abstract/Free Full Text]
-
Lindenboim L,
Haviv R,
Stein R
(1995)
Inhibition of drug-induced apoptosis by survival factors in PC12 cells.
J Neurochem
64:1054-1063 .
[Web of Science][Medline]
-
Mesner PW,
Winters TR,
Green SH
(1992)
Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons.
J Cell Biol
119:1669-1680 .
[Abstract/Free Full Text]
-
Pittman RN,
Wang S,
DiBenedetto AJ,
Mills JC
(1993)
A system for characterizing cellular and molecular events in programmed neuronal cell death.
J Neurosci
13:3669-3680 .
[Abstract]
-
Rukenstein A,
Rydel RE,
Greene LA
(1991)
Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms.
J Neurosci
11:2552-2563 .
[Abstract]
-
Rydel RE,
Greene LA
(1988)
cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor.
Proc Natl Acad Sci USA
85:1257-1261 .
[Abstract/Free Full Text]
-
Schapira AHV
(1995)
Oxidative stress in Parkinson's disease.
Neuropathol Appl Neurobiol
21:3-9.
[Web of Science][Medline]
-
Srinivasan A,
Foster LM,
Testa M-P,
Ord T,
Keane RW,
Bredesen DE,
Kayalar C
(1996)
Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis.
J Neurosci
16:5654-5660 .
[Abstract/Free Full Text]
-
Stefanis L,
Park DS,
Yan CYI,
Farinelli SE,
Troy CM,
Shelanski ML,
Greene LA
(1996)
Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support: dissociation from apoptosis.
J Biol Chem
271:30663-30671 .
[Abstract/Free Full Text]
-
Theodore L,
Derossi D,
Chassaing G,
Llirbat B,
Kubes M,
Jordan P,
Chneilweiss H,
Godement P,
Prochiantz A
(1995)
Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse.
J Neurosci
15:7158-7167 .
[Abstract]
-
Thornberry NA,
Bull HG,
Calaycay JR,
Chapman KT,
Howard AD,
Kostura MJ,
Miller DK,
Molineaux SM,
Weidner JR,
Aunins J,
Elliston KO,
Ayala JM,
Casano FJ,
Chin J,
Ding GJ-F,
Egger LA,
Gaffney EP,
Limjuco G,
Palyha OC,
Raju SM,
Rolando AM,
Salley JP,
Yamin T-T,
Lee TD,
Shively JE,
MacCross M,
Mumford RA,
Schmidt JA,
Tocci MJ
(1992)
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.
Nature
356:768-774 .
[Medline]
-
Troy CM,
Shelanski ML
(1994)
Down-regulation of copper/zinc superoxide dismutase (SOD1) causes neuronal cell death.
Proc Natl Acad Sci USA
91:6384-6387 .
[Abstract/Free Full Text]
-
Troy CM,
Brown K,
Greene LA,
Shelanski ML
(1990)
Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo.
Neuroscience
36:217-237 .
[Web of Science][Medline]
-
Troy CM,
Greene LA,
Shelanski ML
(1992)
Neurite outgrowth in peripherin-depleted PC12 cells.
J Cell Biol
117:1085-1092 .
[Abstract/Free Full Text]
-
Troy CM,
Derossi D,
Prochiantz A,
Greene LA,
Shelanski ML
(1996a)
Downregulation of Cu/Zn SOD1 leads to cell death via the nitric oxide-peroxynitrite pathway.
J Neurosci
16:253-261 .
[Abstract/Free Full Text]
-
Troy CM,
Stefanis L,
Prochiantz A,
Greene LA,
Shelanski ML
(1996b)
The contrasting roles of ICE family proteases and interleukin-1
in apoptosis induced by trophic factor withdrawal and by SOD1 downregulation.
Proc Natl Acad Sci USA
93:5635-5640 .
[Abstract/Free Full Text]
-
Troy CM,
Stefanis L,
Greene LA,
Shelanski ML
(1996c)
Mechanisms of neuronal degeneration: a final common pathway?
In: Neuronal regeneration, reorganization, and repair (Seil F,
ed), pp 103-112. New York: Raven.
-
Wang L,
Miura M,
Bergeron L,
Zhu H,
Yuan J
(1994)
Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death.
Cell
78:739-750 .
[Web of Science][Medline]
-
Williams LR
(1995)
Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic.
Cerebrovasc Brain Metab Rev
7:55-73 .
[Web of Science][Medline]
-
Yamin T-T,
Ayala JM,
Miller DK
(1996)
Activation of the native 45 kDa precursor form of interleukin-1-converting enzyme.
J Biol Chem
271:13273-13282 .
[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
K. Niizuma, H. Endo, C. Nito, D. J. Myer, G. S. Kim, and P. H. Chan
The PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats
PNAS,
October 21, 2008;
105(42):
16368 - 16373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. de La Motte Rouge, L. Galluzzi, K. A. Olaussen, Y. Zermati, E. Tasdemir, T. Robert, H. Ripoche, V. Lazar, P. Dessen, F. Harper, et al.
A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Resistant to Erlotinib
Cancer Res.,
July 1, 2007;
67(13):
6253 - 6262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stefanis
Caspase-Dependent and -Independent Neuronal Death: Two Distinct Pathways to Neuronal Injury
Neuroscientist,
February 1, 2005;
11(1):
50 - 62.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vyas, P. Juin, D. Hancock, Y. Suzuki, R. Takahashi, A. Triller, and G. Evan
Differentiation-dependent Sensitivity to Apoptogenic Factors in PC12 Cells
J. Biol. Chem.,
July 23, 2004;
279(30):
30983 - 30993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, L. Chen, T. J. Maures, J. Herrington, and C. Carter-Su
SH2-B Is a Positive Regulator of Nerve Growth Factor-mediated Activation of the Akt/Forkhead Pathway in PC12 Cells
J. Biol. Chem.,
January 2, 2004;
279(1):
133 - 141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Affaitati, L. Cardone, T. de Cristofaro, A. Carlucci, M. D. Ginsberg, S. Varrone, M. E. Gottesman, E. V. Avvedimento, and A. Feliciello
Essential Role of A-kinase Anchor Protein 121 for cAMP Signaling to Mitochondria
J. Biol. Chem.,
January 31, 2003;
278(6):
4286 - 4294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Troy, J. E. Friedman, and W. J. Friedman
Mechanisms of p75-mediated Death of Hippocampal Neurons. ROLE OF CASPASES
J. Biol. Chem.,
September 6, 2002;
277(37):
34295 - 34302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Qiu, M. J. Whalen, P. Lowenstein, G. Fiskum, B. Fahy, R. Darwish, B. Aarabi, J. Yuan, and M. A. Moskowitz
Upregulation of the Fas Receptor Death-Inducing Signaling Complex after Traumatic Brain Injury in Mice and Humans
J. Neurosci.,
May 1, 2002;
22(9):
3504 - 3511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Troy, S. A. Rabacchi, J. B. Hohl, J. M. Angelastro, L. A. Greene, and M. L. Shelanski
Death in the Balance: Alternative Participation of the Caspase-2 and -9 Pathways in Neuronal Death Induced by Nerve Growth Factor Deprivation
J. Neurosci.,
July 15, 2001;
21(14):
5007 - 5016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. A. Figueroa-Masot, M. Hetman, M. J. Higgins, N. Kokot, and Z. Xia
Taxol Induces Apoptosis in Cortical Neurons by a Mechanism Independent of Bcl-2 Phosphorylation
J. Neurosci.,
July 1, 2001;
21(13):
4657 - 4667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. UBOL and J. KASISITH
Reactivation of Nedd-2, a developmentally down-regulated apoptotic gene, in apoptosis induced by a street strain of rabies virus
J. Med. Microbiol.,
November 1, 2000;
49(11):
1043 - 1046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gotz, C. Karch, M. R. Digby, J. Troppmair, U. R. Rapp, and M. Sendtner
The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells
Hum. Mol. Genet.,
October 1, 2000;
9(17):
2479 - 2489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Savitz and J. A. Kessler
Leukemia Inhibitory Factor Requires Concurrent p75LNTR Signaling to Induce Apoptosis of Cultured Sympathetic Neurons
J. Neurosci.,
June 1, 2000;
20(11):
4198 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mancini, C. E. Machamer, S. Roy, D. W. Nicholson, N. A. Thornberry, L. A. Casciola-Rosen, and A. Rosen
Caspase-2 Is Localized at the Golgi Complex and Cleaves Golgin-160 during Apoptosis
J. Cell Biol.,
May 1, 2000;
149(3):
603 - 612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Troy, S. A. Rabacchi, W. J. Friedman, T. F. Frappier, K. Brown, and M. L. Shelanski
Caspase-2 Mediates Neuronal Cell Death Induced by beta -Amyloid
J. Neurosci.,
February 15, 2000;
20(4):
1386 - 1392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kurokawa, N. Katai, H. Shibuki, S. Kuroiwa, Y. Kurimoto, C. Nakayama, and N. Yoshimura
BDNF Diminishes Caspase-2 but Not c-Jun Immunoreactivity of Neurons in Retinal Ganglion Cell Layer after Transient Ischemia
Invest. Ophthalmol. Vis. Sci.,
November 1, 1999;
40(12):
3006 - 3011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Padmanabhan, D. S. Park, L. A. Greene, and M. L. Shelanski
Role of Cell Cycle Regulatory Proteins in Cerebellar Granule Neuron Apoptosis
J. Neurosci.,
October 15, 1999;
19(20):
8747 - 8756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Katai and N. Yoshimura
Apoptotic Retinal Neuronal Death by Ischemia-Reperfusion Is Executed by Two Distinct Caspase Family Proteases
Invest. Ophthalmol. Vis. Sci.,
October 1, 1999;
40(11):
2697 - 2705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hetman, K. Kanning, J. E. Cavanaugh, and Z. Xia
Neuroprotection by Brain-derived Neurotrophic Factor Is Mediated by Extracellular Signal-regulated Kinase and Phosphatidylinositol 3-Kinase
J. Biol. Chem.,
August 6, 1999;
274(32):
22569 - 22580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stefanis, D. S. Park, W. J. Friedman, and L. A. Greene
Caspase-Dependent and -Independent Death of Camptothecin-Treated Embryonic Cortical Neurons
J. Neurosci.,
August 1, 1999;
19(15):
6235 - 6247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Katai, T. Kikuchi, H. Shibuki, S. Kuroiwa, J. Arai, T. Kurokawa, and N. Yoshimura
Caspaselike Proteases Activated in Apoptotic Photoreceptors of Royal College of Surgeons Rats
Invest. Ophthalmol. Vis. Sci.,
July 1, 1999;
40(8):
1802 - 1886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Johnson, Y. Kinoshita, H. Xiang, S. Ghatan, and R. S. Morrison
Contribution of p53-Dependent Caspase Activation to Neuronal Cell Death Declines with Neuronal Maturation
J. Neurosci.,
April 15, 1999;
19(8):
2996 - 3006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Gu, P. Casaccia-Bonnefil, A. Srinivasan, and M. V. Chao
Oligodendrocyte Apoptosis Mediated by Caspase Activation
J. Neurosci.,
April 15, 1999;
19(8):
3043 - 3049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stefanis, C. M. Troy, H. Qi, M. L. Shelanski, and L. A. Greene
Caspase-2 (Nedd-2) Processing and Death of Trophic Factor-Deprived PC12 Cells and Sympathetic Neurons Occur Independently of Caspase-3 (CPP32)-Like Activity
J. Neurosci.,
November 15, 1998;
18(22):
9204 - 9215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Park, E. J. Morris, J. Padmanabhan, M. L. Shelanski, H. M. Geller, and L. A. Greene
Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents
J. Cell Biol.,
October 19, 1998;
143(2):
457 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yang, R. T. Matthews, J. B. Schulz, T. Klockgether, A. W. Liao, J.-C. Martinou, J. B. Penney Jr., B. T. Hyman, and M. F. Beal
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2
J. Neurosci.,
October 15, 1998;
18(20):
8145 - 8152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Krohn, E. Preis, and J. H. M. Prehn
Staurosporine-Induced Apoptosis of Cultured Rat Hippocampal Neurons Involves Caspase-1-Like Proteases as Upstream Initiators and Increased Production of Superoxide as a Main Downstream Effector
J. Neurosci.,
October 15, 1998;
18(20):
8186 - 8197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Colussi, N. L. Harvey, and S. Kumar
Prodomain-dependent Nuclear Localization of the Caspase-2 (Nedd2) Precursor. A NOVEL FUNCTION FOR A CASPASE PRODOMAIN
J. Biol. Chem.,
September 18, 1998;
273(38):
24535 - 24542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Lipton and P. Nicotera
{blacksquare} REVIEW : Excitotoxicity, Free Radicals, Necrosis, and Apoptosis
Neuroscientist,
September 1, 1998;
4(5):
345 - 352.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Back, X. Gan, Y. Li, P. A. Rosenberg, and J. J. Volpe
Maturation-Dependent Vulnerability of Oligodendrocytes to Oxidative Stress-Induced Death Caused by Glutathione Depletion
J. Neurosci.,
August 15, 1998;
18(16):
6241 - 6253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kitagawa, T. Hayashi, Y. Mitsumoto, N. Koga, Y. Itoyama, K. Abe, and H. A. Kontos
Reduction of Ischemic Brain Injury by Topical Application of Glial Cell Line–Derived Neurotrophic Factor After Permanent Middle Cerebral Artery Occlusion in Rats • Editorial Comment
Stroke,
July 1, 1998;
29(7):
1417 - 1422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bergeron, G. I. Perez, G. Macdonald, L. Shi, Y. Sun, A. Jurisicova, S. Varmuza, K. E. Latham, J. A. Flaws, J. C.M. Salter, et al.
Defects in regulation of apoptosis in caspase-2-deficient mice
Genes & Dev.,
May 1, 1998;
12(9):
1304 - 1314.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. J. Butt, N. L. Harvey, G. Parasivam, and S. Kumar
Dimerization and Autoprocessing of the Nedd2 (Caspase-2) Precursor Requires both the Prodomain and the Carboxyl-terminal Regions
J. Biol. Chem.,
March 20, 1998;
273(12):
6763 - 6768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Blomer, T. Kafri, L. Randolph-Moore, I. M. Verma, and F. H. Gage
Bcl-xL protects adult septal cholinergic neurons from axotomized cell death
PNAS,
March 3, 1998;
95(5):
2603 - 2608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Park, E. J. Morris, L. Stefanis, C. M. Troy, M. L. Shelanski, H. M. Geller, and L. A. Greene
Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress
J. Neurosci.,
February 1, 1998;
18(3):
830 - 840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Caldero, D. Prevette, X. Mei, R. A. Oakley, L. Li, C. Milligan, L. Houenou, M. Burek, and R. W. Oppenheim
Peripheral Target Regulation of the Development and Survival of Spinal Sensory and Motor Neurons in the Chick Embryo
J. Neurosci.,
January 1, 1998;
18(1):
356 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Park, B. Levine, G. Ferrari, and L. A. Greene
Cyclin Dependent Kinase Inhibitors and Dominant Negative Cyclin Dependent Kinase 4 and 6 Promote Survival of NGF-Deprived Sympathetic Neurons
J. Neurosci.,
December 1, 1997;
17(23):
8975 - 8983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Z. Anastasiadis, H. Jiang, L. Bezin, D. M. Kuhn, and R. A. Levine
Tetrahydrobiopterin Enhances Apoptotic PC12 Cell Death following Withdrawal of Trophic Support
J. Biol. Chem.,
March 16, 2001;
276(12):
9050 - 9058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cote, S. Dupuis, and J. Y. Wu
Polypyrimidine Track-binding Protein Binding Downstream of Caspase-2 Alternative Exon 9 Represses Its Inclusion
J. Biol. Chem.,
March 9, 2001;
276(11):
8535 - 8543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Angelastro, N. Y. Moon, D. X. Liu, A.-S. Yang, L. A. Greene, and T. F. Franke
Characterization of a Novel Isoform of Caspase-9 That Inhibits Apoptosis
J. Biol. Chem.,
April 6, 2001;
276(15):
12190 - 12200.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|